InvestorsHub Logo
Followers 0
Posts 177
Boards Moderated 0
Alias Born 06/22/2011

Re: None

Tuesday, 07/19/2011 10:42:28 PM

Tuesday, July 19, 2011 10:42:28 PM

Post# of 7054
LaViv to follow in Provenge's Footsteps

Doing some more research and have decided that it is more compelling to compare LaViv to Provenge (rather than Botox).

Seeking Alpha was onto this last month, but I somehow missed the comparison.

http://seekingalpha.com/news-article/1317401-fibrocell-s-laviv-gets-nod-in-lucrative-aesthetics-market


The parallels between Dendreon and Fibrocell are striking and IMO serve for better comparison. In the two years since approval DNDN has gone from $3 to over $30. We may not see our profit immediately but it will pay off to those of us who have patience.